Skip to main content
Signal8

Longduoduo Co Ltd (LDDD)

Sector: Services-Health Services

Industry: Medical - Diagnostics & Research

Longduoduo Company Limited logo

Longduoduo Company Limited

OTC:LDDDHealthcare
Mkt Cap-
EV-
Float9.71M
O/S30.02M
Inst Own-
SI<0.1%
Net Cash/Sh-
Dilution
Historical Data
DateOpenHighLowCloseVolume
Oct 23, 20260.51000.51000.51000.51001,000
Oct 22, 20260.51000.51000.51000.51001,000
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
Insider Trades
No insider transactions for this companyForeign private issuers and non-reporting entities don't file Form 4/5.
Shareholders
--
Institutional
(0)
--
Insiderⓘ
(0)
--
5%+ Owners
(0)
--
Unattributed (incl. retail)ⓘ
Sources:
About

Longduoduo Company Limited, along with its associated entities, operates within the People's Republic of China, focusing on providing proactive health management and preventative medical services.

The company's comprehensive suite of offerings includes health screenings, diverse treatment options, and specialized healthcare products, all aimed at reducing the likelihood of severe conditions such as myocardial infarction (heart attacks), cerebral infarction (strokes), hemiplegia (paralysis), and other cardiovascular and cerebrovascular diseases. These services are delivered through an extensive network of external collaborators, including independent healthcare providers, product vendors, and sales representatives.

Additionally, Longduoduo features a range of advanced therapeutic interventions. These encompass meridian-regulating and consciousness-restoring techniques, a double blood purification process, immunological ozonated autohemotherapy, platelet-rich plasma therapy, relaxation techniques, vegetative nerve regulation, and microwave therapy. Established in 2020, the firm's primary operational base is located in Hohhot, China.

Key Metrics
Market Cap--
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership-

No 13F filer reports a position yet. 13F reports are quarterly and are filed up to 45 days after the quarter ends.

SectorHealthcare
IndustryMedical - Diagnostics & Research
ExchangeOTC
CountryCNCN
IPO Date-
Shares Outstanding30.02M
Authorized Shares
Float9.71M
52-Week Range
Volume
Average Daily Volume1.00K

30d Avg

1.00K

60d Avg

1.00K

90d Avg

1.00K

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...